Product
177Lu-PSMA-1
1 clinical trial
1 indication
Indication
Clear Cell Renal Cell CarcinomaClinical trial
A Multicentric, Single Arm, Open-label, Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal CancerStatus: Recruiting, Estimated PCD: 2026-04-01